Evidence map›Paper›PMID 32354716›Full record

Trial reportAJNR. American journal of neuroradiology2020

Tumor Response Assessment in Diffuse Intrinsic Pontine Glioma: Comparison of Semiautomated Volumetric, Semiautomated Linear, and Manual Linear Tumor Measurement Strategies.

L A Gilligan, M D DeWire-Schottmiller, M Fouladi, P DeBlank, J L Leach

Registry-linked trialOpen access · hybridAbstract readClinical Trial, Phase IClinical Trial, Phase II
In one paragraph

Trial report in AJNR. American journal of neuroradiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02607124 (A Phase I/II Study of Ribociclib, a CDK4/6 Inhibitor, Following Radiation Therapy in Children With Newly Diagnosed Non-biopsied Diffuse Pontine Gliomas), which is not on this map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02607124 phase1 / phase2terminatednot on this map

A Phase I/II Study of Ribociclib, a CDK4/6 Inhibitor, Following Radiation Therapy in Children With Newly Diagnosed Non-biopsied Diffuse Pontine Gliomas (DIPG) and RB+ Biopsied DIPG and High Grade Gliomas (HGG)

TypeinterventionalSponsorChildren's Hospital Medical Center, CincinnatiRan2016 to 2018Enrolled11ConditionsHigh Grade Glioma, Diffuse Intrinsic Pontine Glioma, Bithalamic High Grade GliomaArmsRibociclib
3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 16 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 3 countries.

L A GilliganFrom the Departments of Radiology (L.A.G., J.L.L.).ORCID 0000-0002-4632-7004
M D DeWire-Schottmillerand Cancer and Blood Diseases Institute (M.D.D.-S., M.F.), Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.ORCID 0000-0002-8084-2720
M Fouladiand Cancer and Blood Diseases Institute (M.D.D.-S., M.F.), Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.ORCID 0000-0002-5693-035X
P DeBlankand Departments of Pediatrics (M.F., P.D.).ORCID 0000-0001-6623-3040
J L LeachFrom the Departments of Radiology (L.A.G., J.L.L.) james.leach@cchmc.org.ORCID 0000-0002-6574-9982
Cincinnati Children's Hospital Medical Center · USGovernment Medical College · INMount Carmel Health · USNeurology, Inc · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purpose2D measurements of diffuse intrinsic pontine gliomas are limited by variability, and volumetric response criteria are poorly defined. Semiautomated 2D measurements may improve consistency; however, the impact on tumor response assessments is unknown. The purpose of this study was to compare manual 2D, semiautomated 2D, and volumetric measurement strategies for diffuse intrinsic pontine gliomas. MATERIALS AND

methodsThis study evaluated patients with diffuse intrinsic pontine gliomas through a Phase I/II trial (NCT02607124). Clinical 2D cross-product values were derived from manual linear measurements (cross-product = long axis × short axis). By means of dedicated software (mint Lesion), tumor margins were traced and maximum cross-product and tumor volume were automatically derived. Correlation and bias between methods were assessed, and response assessment per measurement strategy was reported.

resultsTen patients (median age, 7.6 years) underwent 58 MR imaging examinations. Correlation and mean bias (95% limits) of percentage change in tumor size from prior examinations were the following: clinical and semiautomated cross-product,

conclusionsManual 2D cross-product measurements may underestimate tumor size and disease progression compared with semiautomated 2D and volumetric measurements.

Indexed as

AdolescentAminopyridinesBrain Stem NeoplasmsChemoradiotherapyChemotherapy, AdjuvantChildDiffuse Intrinsic Pontine GliomaFemaleHumansImage Interpretation, Computer-AssistedMagnetic Resonance ImagingMaleNeuroimagingPurinesSoftwareTumor BurdenAminopyridinesPurinesribociclib

Identifiers

PMID32354716
PMCPMC7228153
OpenAlexW3021166260

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.